Thursday, 20 October 2022
Nanotechnology for improved natural-look ocular prostheses
The ICN2 and CSIC are partnering with Art-lens to develop better ocular prosthetic solutions for patients that have lost an eye. From the ICN2 side, the project will be led by Dr Claudio Roscini from the Nanosfun group.
The ICN2 Nanostructured Functional Materials Group (Nanosfun), led by Prof. Daniel Ruiz-Molina, researcher of the Consejo Superior de Investigaciones Científicas-CSIC is extended its collaboration with the company Art-Lens to develop a research study in which the specific knowledge and expertise of the partners will be combined to develop an healthcare product. Specifically, they will apply a nanotechnology patented by the ICN2, the CSIC and the Universitat Autònoma de Barcelona (UAB) to ocular prostheses with the aim of providing substantial improvements in the patient's quality of life and well-being.
Art-Lens is specialised in the development of custom ocular prostheses, contact lenses and facial prostheses that have a very natural look and that are designed to meet the specific needs of each patient. By using a wide range of materials and state-of-the-art technologies, they provide fully personalized service to people who have suffered the loss of an eye.
The objective of this project, which will be led by Dr Claudio Roscini for the part that concerns the ICN2, is to apply nanotechnologies and the expertise of the Nanosfun group in chromogenic nanomaterials to design ocular prostheses that looks even more like real human eyes. A follow-up to a previous collaborative study, this new project shows, once again, the Nanosfun group's compromise with research leading to medium/short term applications for social and environmental challenges, as well as Art-Lens' commitment to knowledge and innovation and the exploration of new technological solutions.